{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:51:21Z","timestamp":1788893481174,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014969","name":"Guilin Medical University","doi-asserted-by":"publisher","award":["2024SRP125"],"award-info":[{"award-number":["2024SRP125"]}],"id":[{"id":"10.13039\/501100014969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270745"],"award-info":[{"award-number":["82270745"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070721"],"award-info":[{"award-number":["82070721"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270798"],"award-info":[{"award-number":["82270798"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024A1515012699"],"award-info":[{"award-number":["2024A1515012699"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2020A1515011461"],"award-info":[{"award-number":["2020A1515011461"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013092","name":"Science and Technology Planning Project of Fuzhou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013092","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.lfs.2025.123608","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T19:53:14Z","timestamp":1743969194000},"page":"123608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Mesenchymal stem cells attenuate hyperoxaluria-induced kidney injury and crystal depositions via inhibiting the activation of NLRP3 inflammasome"],"prefix":"10.1016","volume":"371","author":[{"given":"Bangyu","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houmeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongda","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2025.123608_bb0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00345-017-2008-6","article-title":"Epidemiology of stone disease across the world","volume":"35","author":"Sorokin","year":"2017","journal-title":"World. J. Urol."},{"key":"10.1016\/j.lfs.2025.123608_bb0010","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.eururo.2012.03.052","article-title":"Prevalence of kidney stones in the United States","volume":"62","author":"Scales","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.lfs.2025.123608_bb0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.suc.2016.02.008","article-title":"Diagnosis and management of nephrolithiasis","volume":"96","author":"Ingimarsson","year":"2016","journal-title":"Surg. Clin. North Am."},{"key":"10.1016\/j.lfs.2025.123608_bb0020","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1681\/ASN.2013091011","article-title":"The ROKS nomogram for predicting a second symptomatic stone episode","volume":"25","author":"Rule","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2025.123608_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/nu14234961","article-title":"Unravelling the complex relationship between diet and nephrolithiasis: the role of nutrigenomics and nutrigenetics","volume":"14","author":"D\u2019Ambrosio","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2025.123608_bb0030","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrneph.2017.10","article-title":"Crystal nephropathies: mechanisms of crystal-induced kidney injury","volume":"13","author":"Mulay","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.lfs.2025.123608_bb0035","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ki.2013.207","article-title":"NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy","volume":"84","author":"Knauf","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2025.123608_bb0040","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1172\/JCI63679","article-title":"Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1\u03b2 secretion","volume":"123","author":"Mulay","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2025.123608_bb0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13287-024-03885-z","article-title":"Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities","volume":"15","author":"Zhidu","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.lfs.2025.123608_bb0050","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","article-title":"Stem cell-based therapy for human diseases","volume":"7","author":"Hoang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.lfs.2025.123608_bb0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2478\/s11658-011-0019-7","article-title":"Perinatal sources of mesenchymal stem cells: Wharton\u2019s jelly, amnion and chorion","volume":"16","author":"Witkowska-Zimny","year":"2011","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.lfs.2025.123608_bb0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.lfs.2025.123608_bb0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13287-016-0363-7","article-title":"Mechanisms of mesenchymal stem\/stromal cell function","volume":"7","author":"Spees","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.lfs.2025.123608_bb0070","article-title":"Current understanding of the mesenchymal stem cell-derived exosomes in cancer and aging","volume":"31","author":"Muralikumar","year":"2021","journal-title":"Biotechnol. Rep. (Amsterdam, Netherlands)"},{"key":"10.1016\/j.lfs.2025.123608_bb0075","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3577015","article-title":"Extracellular vesicles of mesenchymal stem cells are more effectively accessed through polyethylene glycol-based precipitation than by ultracentrifugation","volume":"2022","author":"Jia","year":"2022","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.lfs.2025.123608_bb0080","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1111\/jcmm.15081","article-title":"Different culture method changing CD105 expression in amniotic fluid MSCs without affecting differentiation ability or immune function","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2025.123608_bb0085","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3892\/ijmm.2014.1821","article-title":"Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation","volume":"34","author":"Li","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2025.123608_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/scrt442","article-title":"Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly","volume":"5","author":"Amable","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.lfs.2025.123608_bb0095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.arcmed.2020.08.006","article-title":"Mesenchymal stem cells current clinical applications: a systematic review","volume":"52","author":"Rodr\u00edguez-Fuentes","year":"2021","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.lfs.2025.123608_bb0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/14653240600920782","article-title":"Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM","volume":"8","author":"M\u00fcller","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.lfs.2025.123608_bb0105","article-title":"Therapeutic mesenchymal stem\/stromal cells: value, challenges and optimization","volume":"9","author":"Najar","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.lfs.2025.123608_bb0110","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13287-021-02218-8","article-title":"MSCs derived from amniotic fluid and umbilical cord require different administration schemes and exert different curative effects on different tissues in rats with CLP-induced sepsis","volume":"12","author":"Chen","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.lfs.2025.123608_bb0115","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/7651_2019_242","article-title":"Isolation, expansion, and characterization of Wharton's jelly-derived mesenchymal stromal cell: method to identify functional passages for experiments","volume":"2045","author":"Aung","year":"2019","journal-title":"Methods Mol. Biol. (Clifton, N.J.)"},{"key":"10.1016\/j.lfs.2025.123608_bb0120","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.lfs.2025.123608_bb0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2013.282909","article-title":"Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial","volume":"311","author":"Heldman","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.lfs.2025.123608_bb0130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","article-title":"Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial","volume":"3","author":"Wilson","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.lfs.2025.123608_bb0135","doi-asserted-by":"crossref","first-page":"8558","DOI":"10.1111\/jcmm.16817","article-title":"Mesenchymal stem cells from different sources show distinct therapeutic effects in hyperoxia-induced bronchopulmonary dysplasia in rats","volume":"25","author":"Xie","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2025.123608_bb0140","article-title":"Potential and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for acute\/chronic kidney disease","volume":"20","author":"Yun","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2025.123608_bb0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00240-007-0082-8","article-title":"Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection","volume":"35","author":"Okada","year":"2007","journal-title":"Urol. Res."},{"key":"10.1016\/j.lfs.2025.123608_bb0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11010-007-9661-9","article-title":"Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells","volume":"310","author":"Yu","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lfs.2025.123608_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100246","article-title":"Preparation and culture of bone marrow-derived macrophages from mice for functional analysis","volume":"2","author":"Toda","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.lfs.2025.123608_bb0160","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/s41467-018-04717-4","article-title":"C-terminal truncation of IFN-\u03b3 inhibits proinflammatory macrophage responses and is deficient in autoimmune disease","volume":"9","author":"Dufour","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2025.123608_bb0165","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cca.2005.11.033","article-title":"Factors determining types and morphologies of calcium oxalate crystals: molar concentrations, buffering, pH, stirring and temperature","volume":"367","author":"Thongboonkerd","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.lfs.2025.123608_bb0170","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1172\/JCI37829","article-title":"Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models","volume":"119","author":"Brooks","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2025.123608_bb0175","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/12.5.333","article-title":"Histochemical recognition of calcium oxalate","volume":"12","author":"Pizzolato","year":"1964","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.lfs.2025.123608_bb0180","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2215\/CJN.05660614","article-title":"Stone composition as a function of age and sex","volume":"9","author":"Lieske","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2025.123608_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/nu13010062","article-title":"Contribution of dietary oxalate and oxalate precursors to urinary oxalate excretion","volume":"13","author":"Crivelli","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2025.123608_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154429","article-title":"Gallic acid ameliorates calcium oxalate crystal-induced renal injury via upregulation of Nrf2\/HO-1 in the mouse model of stone formation","volume":"106","author":"Zhou","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.lfs.2025.123608_bb0195","article-title":"Molecular mechanisms of mesenchymal stem cell-based therapy in acute kidney injury","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2025.123608_bb0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","article-title":"The MSC: an injury drugstore","volume":"9","author":"Caplan","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.lfs.2025.123608_bb0205","doi-asserted-by":"crossref","first-page":"23736","DOI":"10.1002\/jcp.28941","article-title":"Exosomes from human-bone-marrow-derived mesenchymal stem cells protect against renal ischemia\/reperfusion injury via transferring miR-199a-3p","volume":"234","author":"Zhu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2025.123608_bb0210","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.7150\/thno.54550","article-title":"Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury","volume":"11","author":"Cao","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2025.123608_bb0215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcyt.2017.08.002","article-title":"HucMSC exosome-transported 14-3-3\u03b6 prevents the injury of cisplatin to HK-2 cells by inducing autophagy in vitro","volume":"20","author":"Wang","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.lfs.2025.123608_bb0220","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/scrt469","article-title":"Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages","volume":"5","author":"Geng","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.lfs.2025.123608_bb0225","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s13287-020-01852-y","article-title":"Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis","volume":"11","author":"Xiang","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.lfs.2025.123608_bb0230","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.2147\/IJN.S299969","article-title":"Mesenchymal stem cells attenuate renal fibrosis via exosomes-mediated delivery of microRNA let-7i-5p antagomir","volume":"16","author":"Jin","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.lfs.2025.123608_bb0235","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pharmthera.2015.03.006","article-title":"Pericytes, mesenchymal stem cells and their contributions to tissue repair","volume":"151","author":"Wong","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2025.123608_bb0240","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00018-017-2473-5","article-title":"Interactions between mesenchymal stem cells and the immune system","volume":"74","author":"Li","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2025.123608_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109251","article-title":"Numb ameliorates necrosis and inflammation in acute kidney injury induced by cisplatin","volume":"330","author":"Liu","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2025.123608_bb0250","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s43141-022-00427-z","article-title":"Evaluation of the effectiveness of two new strains of Lactobacillus on obesity-induced kidney diseases in BALB\/c mice","volume":"20","author":"Darwish","year":"2022","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.lfs.2025.123608_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101717","article-title":"Macrophage polarization in kidney transplant patients","volume":"75","author":"Devraj","year":"2022","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.lfs.2025.123608_bb0260","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/ndt\/gfy239","article-title":"Targeting kidney inflammation as a new therapy for primary hyperoxaluria?","volume":"34","author":"Martin-Higueras","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.lfs.2025.123608_bb0265","article-title":"Involvement of inflammasome components in kidney disease","volume":"11","author":"Aranda-Rivera","year":"2022","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.lfs.2025.123608_bb0270","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41419-018-0378-3","article-title":"Hydroxychloroquine attenuates renal ischemia\/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation","volume":"9","author":"Tang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2025.123608_bb0275","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cell.2013.02.054","article-title":"The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation","volume":"153","author":"Subramanian","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2025.123608_bb0280","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1111\/febs.13379","article-title":"Role of the nucleotide-binding domain-like receptor protein 3 inflammasome in acute kidney injury","volume":"282","author":"Cao","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.lfs.2025.123608_bb0285","doi-asserted-by":"crossref","first-page":"F997","DOI":"10.1152\/ajprenal.00130.2004","article-title":"Endotoxemic acute renal failure is attenuated in caspase-1-deficient mice","volume":"288","author":"Wang","year":"2005","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.lfs.2025.123608_bb0290","doi-asserted-by":"crossref","first-page":"F621","DOI":"10.1152\/ajprenal.00344.2015","article-title":"Mesenchymal stem cell transplantation inhibited high salt-induced activation of the NLRP3 inflammasome in the renal medulla in Dahl S rats","volume":"310","author":"Zhu","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.lfs.2025.123608_bb0295","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.biopha.2018.04.038","article-title":"The rescue effect of mesenchymal stem cell on sodium iodate-induced retinal pigment epithelial cell death through deactivation of NF-\u03baB-mediated NLRP3 inflammasome","volume":"103","author":"Mao","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2025.123608_bb0300","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3021750","article-title":"Ultrashort wave combined with human umbilical cord mesenchymal stem cell (HUC-MSC) transplantation inhibits NLRP3 inflammasome and improves spinal cord injury via MK2\/TTP signalling pathway","volume":"2020","author":"Na","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2025.123608_bb0305","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3389\/fimmu.2019.01645","article-title":"Mesenchymal stromal cell therapeutic delivery: translational challenges to clinical application","volume":"10","author":"Caplan","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.123608_bb0310","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.lfs.2025.123608_bb0315","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/sctm.19-0202","article-title":"Trends in mesenchymal stem cell clinical trials 2004\u20132018: is efficacy optimal in a narrow dose range?","volume":"9","author":"Kabat","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.lfs.2025.123608_bb0320","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet (London, England)"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525002425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525002425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:13:18Z","timestamp":1762211598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525002425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":64,"alternative-id":["S0024320525002425"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123608","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stem cells attenuate hyperoxaluria-induced kidney injury and crystal depositions via inhibiting the activation of NLRP3 inflammasome","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123608"}}